Navigation Links
Prestigious fellowship for young Nottingham researcher
Date:2/3/2009

A promising young researcher at The University of Nottingham has been awarded a prestigious national fellowship to support her work investigating the molecular biology of hepatitis C virus.

Dr Catherine Jopling, of the University's School of Pharmacy, has received more than 1 million in funding over five years from a David Phillips fellowship given by the Biotechnology and Biological Sciences Research Council (BBSRC).

Dr Jopling said: "I'm delighted to have been awarded this fellowship. It will be enormously helpful in allowing me to set up my own group and to pursue this exciting research."

The fellowship will cover her salary and provide research funding to allow her to continue with work started while a postdoctoral researcher at Stanford University in the US looking at micro-RNAs, tiny molecules that play a major part in controlling gene expression in cells.

Dr Jopling's research focuses on miR-122, a specialised liver microRNA which interacts with hepatitis C virus (HCV) in an unusual way and plays an important role in helping the virus to replicate itself, an essential part of the viral life cycle.

Hepatitis C is a blood-borne infectious disease which currently affects around two per cent of the population. The infection can go undetected for a long period of time because it often produces no or few symptoms but as the disease becomes more chronic it can lead to serious scarring of the liver (cirrhosis) and even cancer.

Dr Jopling's research looking at how HCV hijacks miR122 to help in its attack on the liver has been recognised by the BBSRC because of the important role it plays in developing our understanding of gene expression and the basic biology of microRNA activity. In the future, the work may also have implications for medical advances if more can be understood about the process by which HCV replicates and spreads, new drugs which act by blocking this action could be developed to help halt the progression of the disease.

The BBSRC awards six to 10 David Phillips fellowships a year to young scientists who have shown huge potential in their early research work and allows them to become well established in their chosen field.

Dr Jopling carried out her PhD from 1998-2001 at the University of Leicester, before obtaining a Wellcome Trust International Research Fellowship, which allowed her to work as a postdoctoral researcher at Stanford University. The fellowship provided a further year of funding to return to a UK-based lab and she spent a year working at the University of Cambridge. She joined Nottingham in 2007 as part of the RNA Biology Group in the School of Pharmacy.


'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
4. Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
5. Jerry Lewis to Receive Prestigious Award From Motion Picture Academy
6. Arthritis Foundation bestows prestigious national research award
7. Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence
8. Melissa Murer Corrigan Receives Prestigious NOCA Leadership Award
9. Capital BlueCross Receives Prestigious Corporation of the Year Award
10. U of T professor first Canadian woman to win prestigious international science prize
11. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... in Building 2. The clinic is the group’s second in New Braunfels and 22nd ... company’s second New Braunfels location brings things full circle for the group, “It’s crazy ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... to $11 trillion dollars by the year 2025. McKinsey expects the IoT to have ...
(Date:3/23/2017)... ... 23, 2017 , ... 82% of adults are unaware of the dangers that infectious bacteria play ... the minimum two times a day that dentists recommend. The ramifications of improper oral upkeep ... school and adults missing 164 million hours of work each year due to dental issues. ...
(Date:3/23/2017)... ... , ... March is National Kidney Month – the perfect time to pause ... good health. Every day, two kidneys filter about 120 to 150 quarts of blood. ... eliminating waste, regulating fluid levels and blood pressure, supporting bone health and promoting red ...
(Date:3/23/2017)... ... 2017 , ... The StayWell Company announced today that it ... StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and ... programs for the delivery and improvement of disease management and that meet or ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... FinancialBuzz.com News Commentary  ... According to new data published Arcview ... legal cannabis market is projected to continue to grow at ... the current presidential administration. The report created by Arcview,s data ... growth in this industry are the passage and subsequent implementation ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced the ... report to their offering. ... The IPF pipeline is very strong with a total of 97 ... Inc., Biogen and Sanofi are involved in the development of the IPF ... is in Phase III stage, 15 are in Phase II stage, 12 ...
(Date:3/24/2017)... March 24, 2017 A ReportsnReports.com report says, ... growing rapidly as the global sales of Adcetris and Kadcyla have ... the antibody drug conjugates market is driven by large number of ... wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major ...
Breaking Medicine Technology: